Research Use Only : This product is sold strictly for research purposes and is not intended for human consumption, therapeutic use, or veterinary applications
This approval was primarily based on the results of the Phase 3 SURMOUNT-OSA clinical trial, which evaluated the efficacy of Zepbound (10 mg or 15 mg) in treating moderate to severe OSA in obese patients, regardless of whether they used positive airway pressure (PAP) therapy
Notably, this pathway substantially overlaps with, and is now often considered synonymous to, a previously described oxidative stress-induced neuronal death process termed oxytosis. The consolidated term oxytosis/ferroptosis has been adopted in the neuroscience literature, reflecting a consensus that these represent the same fundamental cell death pathway (Lewerenz et al., 2018)
Diabetes in adults nearly doubles worldwide, study suggests Wearable technology trend now includes healthy people tracking their blood glucose
Excessive mitochondrial division triggered by mutated HTT may play an important role in the striatums susceptibility to the disease [166,172]
The storage and handling requirements are identical